Fort Collins Consultants In Pathology is categorized under Doctors in Fort Collins, CO and active since 2001.
Fort Collins Consultants In Pathology was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Nancy Ball at the company’s single location by writing to 3351 Eastbrook Drive # 100, Fort Collins, Colorado CO 80525 or by phoning (970) 484-2850. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fort Collins Consultants In Pathology |
| Contact Person: | Nancy Ball |
| Address: | 3351 Eastbrook Drive # 100, Fort Collins, Colorado 80525 |
| Phone Number: | (970) 484-2850 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Fort Collins Consultants In Pathology was started in 2001 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Nancy Ball for inquiries that concern Fort Collins Consultants In Pathology by calling the company number (970) 484-2850, as your correspondence is most welcome. Additionally, the physical location of the single location of Fort Collins Consultants In Pathology can be found at the coordinates 40.542189,-105.04166 as well as the street address 3351 Eastbrook Drive # 100 in Fort Collins, Colorado 80525.
For its online presence, you may visit Fort Collins Consultants In Pathology’s website at and engage with its social media outlets through on Twitter and on Facebook.